Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.

about

Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.

Item

http://www.wikidata.org/entity/Q35670030

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.

@ast

Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.

@en

type

Item

label

Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.

@ast

Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.

@en

prefLabel

Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.

@ast

Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.

@en

P1476

Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.

@en

P2093

Abdul M Choudhury

http://www.w3.org/2001/XMLSchema#string

Tawee Tanvetyanon

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Cancer immunotherapy: the interferon-alpha experience.

Potential of interferon-alpha in solid tumours: part 2.

Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors.

Severe increase in creatinine with hypocalcaemia in thalidomide-treated myeloma patients receiving zoledronic acid infusions.

Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency.

Toxic acute tubular necrosis following treatment with zoledronate (Zometa).

Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.

Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.

Tumor lysis syndrome

P304

418-421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1D357

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14970365

http://www.w3.org/2001/XMLSchema#string